Literature DB >> 3728693

Gated in vivo examination of cardiac metabolites with 31P nuclear magnetic resonance.

H L Kantor, R W Briggs, K R Metz, R S Balaban.   

Abstract

Phosphorus-31 nuclear magnetic resonance (31P NMR) spectroscopy was used to study the temporal aspects of metabolism of canine heart in vivo. An NMR catheter coil was passed through the jugular vein of a dog into the apex of the right ventricle, and spectra were recorded at four points in the cardiac cycle by triggering from the blood pressure trace of the animal. The 31P spin-lattice relaxation times of phosphocreatine (PC) and the gamma-, alpha-, and beta-phosphates of ATP at 1.89 Tesla are 4.4, 1.8, 1.7, and 1.6 s, respectively. The ratio of PC to ATP is 2.0. No changes in PC/ATP were noted in any of the four portions of the cardiac cycle examined, and difference spectra exhibited no observable signals, in contrast to previously reported results for glucose-perfused rat hearts. On the assumption that intracellular pH and the total creatine pool were constant, the equilibrium expression for the creatine kinase reaction was used to deduce that free ADP concentrations were invariant throughout the cardiac cycle. This is in apparent disagreement with the proposed regulatory role for ADP in heart oxidative phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3728693     DOI: 10.1152/ajpheart.1986.251.1.H171

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  A three-dimensional simulation model of cardiomyocyte integrating excitation-contraction coupling and metabolism.

Authors:  Asuka Hatano; Jun-ichi Okada; Takumi Washio; Toshiaki Hisada; Seiryo Sugiura
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

2.  Control of mitochondrial respiration in the heart in vivo.

Authors:  R S Balaban; F W Heineman
Journal:  Mol Cell Biochem       Date:  1989-09-07       Impact factor: 3.396

3.  Increased work in cardiac trabeculae causes decreased mitochondrial NADH fluorescence followed by slow recovery.

Authors:  R Brandes; D M Bers
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

Review 4.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

5.  Phosphorus-31 nuclear magnetic resonance analysis of transient changes of canine myocardial metabolism in vivo.

Authors:  F W Heineman; R S Balaban
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium.

Authors:  Craig S Smith; Paul A Bottomley; Steven P Schulman; Gary Gerstenblith; Robert G Weiss
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

7.  ATP flux through creatine kinase in the normal, stressed, and failing human heart.

Authors:  Robert G Weiss; Gary Gerstenblith; Paul A Bottomley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

8.  Overexpressed ski efficiently promotes neurorestoration, increases neuronal regeneration, and reduces astrogliosis after traumatic brain injury.

Authors:  Yu Zhai; Shi-Yang Ye; Qiu-Shi Wang; Ren-Ping Xiong; Sheng-Yu Fu; Hao Du; Ya-Wei Xu; Yan Peng; Zhi-Zhong Huang; Nan Yang; Yan Zhao; Ya-Lei Ning; Ping Li; Yuan-Guo Zhou
Journal:  Gene Ther       Date:  2022-02-08       Impact factor: 5.250

9.  Downregulation of MicroRNA-145-5p in Activated Microglial Exosomes Promotes Astrocyte Proliferation by Removal of Smad3 Inhibition.

Authors:  Yong Ye; Jie Hao; Zhou Hong; Tong Wu; Xingyu Ge; Boyu Qian; Xiaoqing Chen; Feng Zhang
Journal:  Neurochem Res       Date:  2021-10-08       Impact factor: 3.996

10.  Influence of NAD-linked dehydrogenase activity on flux through oxidative phosphorylation.

Authors:  R Moreno-Sánchez; B A Hogue; R G Hansford
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.